ATLANTA, Ga – By the time the vast majority of people who have HIV reach testing and treatment for the virus, they have had it long enough, Greg Greene of the U.S. Centers for Disease Control and Prevention said here today, that they are vulnerable to deadly fungal infections. One, cryptococcal meningitis, causes 11 percent […]
With social media, cell phone logs, online news reports and electronic medical records, researchers say, “big data” is getting bigger, and can go where traditional infectious disease surveillance can’t . . . The more that was learned about how and where Ebola was spreading during the 2014-2015 crisis in West Africa, the more quickly it […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]